|
1
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143.
2002.
|
|
2
|
Gallino A, Aboyans V, Diehm C, Cosentino
F, Stricker H, Falk E, Schouten O, Lekakis J, Amann-Vesti B,
Siclari F, et al: Non-coronary atherosclerosis. Eur Heart J.
35:1112–1119. 2014.
|
|
3
|
Ross R: Atherosclerosis-an inflammatory
disease. N Engl J Med. 340:115–126. 1999.
|
|
4
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002.
|
|
5
|
Kanai M, Hamada J, Takada M, Asano T,
Murakawa K, Takahashi Y, Murai T, Tada M, Miyamoto M, Kondo S and
Moriuchi T: Aberrant expressions of HOX genes in colorectal and
hepatocellular carcinomas. Oncol Rep. 23:843–851. 2010.
|
|
6
|
Cantile M, Pettinato G, Procino A,
Feliciello I, Cindolo L and Cillo C: In vivo expression of the
whole HOX gene network in human breast cancer. Eur J Cancer.
39:257–264. 2003.
|
|
7
|
Abe M, Hamada J, Takahashi O, Takahashi Y,
Tada M, Miyamoto M, Morikawa T, Kondo S and Moriuchi T: Disordered
expression of Hox genes in human non-small cell lung cancer. Oncol
Rep. 15:797–802. 2006.
|
|
8
|
Lescroart F and Zaffran S: Hox and Tale
transcription factors in heart development and disease. Int J Dev
Biol. 62:837–846. 2018.
|
|
9
|
Poelmann RE, Gittenberger-de Groot AC and
Hierck BP: The development of the heart and microcirculation: Role
of shear stress. Med Biol Eng Comput. 46:479–484. 2008.
|
|
10
|
Makki N and Capecchi MR: Hoxa1 lineage
tracing indicates a direct role for Hoxa1 in the development of the
inner ear, the heart, and the third rhombomere. Dev Biol.
341:499–509. 2010.
|
|
11
|
Yu C, Wu B, Jiang J, Yang G, Weng C and
Cai F: Overexpressed lncRNA ROR promotes the biological
characteristics of ox-LDL-induced HUVECs via the let-7b-5p/HOXA1
axis in atherosclerosis. Front Cardiovasc Med. 8:6597692021.
|
|
12
|
Jing Y, Gao B, Han Z, Xia L and Xin S: The
protective effect of HOXA5 on carotid atherosclerosis occurs by
modulating the vascular smooth muscle cell phenotype. Mol Cell
Endocrinol. 534:1113662021.
|
|
13
|
Luo Z, Rhie SK and Farnham PJ: The
enigmatic HOX genes: Can we crack their code? Cancers (Basel).
11:3232019.
|
|
14
|
Shah N and Sukumar S: The Hox genes and
their roles in oncogenesis. Nat Rev Cancer. 10:361–371. 2010.
|
|
15
|
Lewis EB: A gene complex controlling
segmentation in Drosophila. Nature. 276:565–570. 1978.
|
|
16
|
Chariot A, Gielen J, Merville MP and Bours
V: The homeodomain-containing proteins: An update on their
interacting partners. Biochem Pharmacol. 58:1851–1857. 1999.
|
|
17
|
Rezsohazy R, Saurin AJ, Maurel-Zaffran C
and Graba Y: Cellular and molecular insights into Hox protein
action. Development. 142:1212–1227. 2015.
|
|
18
|
Hudry B, Remacle S, Delfini MC, Rezsohazy
R, Graba Y and Merabet S: Hox proteins display a common and
ancestral ability to diversify their interaction mode with the PBC
class cofactors. PLoS Biol. 10:e10013512012.
|
|
19
|
Banerjee-Basu S and Baxevanis AD:
Molecular evolution of the homeodomain family of transcription
factors. Nucleic Acids Res. 29:3258–3269. 2001.
|
|
20
|
Daftary GS and Taylor HS: Endocrine
regulation of HOX genes. Endocr Rev. 27:331–355. 2006.
|
|
21
|
Lohmann I: Hox genes: Realising the
importance of realisators. Curr Biol. 16:R988–R989. 2006.
|
|
22
|
Krumlauf R: Hox genes, clusters and
collinearity. Int J Dev Biol. 62:659–663. 2018.
|
|
23
|
Beh CY, El-Sharnouby S, Chatzipli A,
Russell S, Choo SW and White R: Roles of cofactors and chromatin
accessibility in Hox protein target specificity. Epigenetics
Chromatin. 9:12016.
|
|
24
|
Rubin E, Wu X, Zhu T, Cheung JC, Chen H,
Lorincz A, Pandita RK, Sharma GG, Ha HC, Gasson J, et al: A role
for the HOXB7 homeodomain protein in DNA repair. Cancer Res.
67:1527–1535. 2007.
|
|
25
|
Comelli L, Marchetti L, Arosio D, Riva S,
Abdurashidova G, Beltram F and Falaschi A: The homeotic protein
HOXC13 is a member of human DNA replication complexes. Cell Cycle.
8:454–459. 2009.
|
|
26
|
Topisirovic I, Kentsis A, Perez JM, Guzman
ML, Jordan CT and Borden KL: Eukaryotic translation initiation
factor 4E activity is modulated by HOXA9 at multiple levels. Mol
Cell Biol. 25:1100–1112. 2005.
|
|
27
|
Bergiers I, Bridoux L, Nguyen N, Twizere
JC and Rezsöhazy R: The homeodomain transcription factor Hoxa2
interacts with and promotes the proteasomal degradation of the E3
ubiquitin protein ligase RCHY1. PLoS One. 8:e803872013.
|
|
28
|
Wang R, Huang Q, Zhou R, Dong Z, Qi Y, Li
H, Wei X, Wu H, Wang H, Wilcox CS, et al: Sympathoexcitation in
rats with chronic heart failure depends on homeobox D10 and
MicroRNA-7b inhibiting GABBR1 translation in paraventricular
nucleus. Circ Heart Fail. 9:e0022612016.
|
|
29
|
Cai S, Liu R, Wang P, Li J, Xie T, Wang M,
Cao Y, Li Z and Liu P: PRMT5 prevents cardiomyocyte hypertrophy via
symmetric dimethylating HoxA9 and repressing HoxA9 expression.
Front Pharmacol. 11:6006272020.
|
|
30
|
Han Z, Guan Y, Liu B, Lin Y, Yan Y, Wang
H, Wang H and Jing B: MicroRNA-99a-5p alleviates atherosclerosis
via regulating Homeobox A1. Life Sci. 232:1166642019.
|
|
31
|
Navab M, Ananthramaiah GM, Reddy ST, Van
Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G,
Kamranpour N, et al: The oxidation hypothesis of atherogenesis: The
role of oxidized phospholipids and HDL. J Lipid Res. 45:993–1007.
2004.
|
|
32
|
Miller YI, Choi SH, Wiesner P, Fang L,
Harkewicz R, Hartvigsen K, Boullier A, Gonen A, Diehl CJ, Que X, et
al: Oxidation-specific epitopes are danger-associated molecular
patterns recognized by pattern recognition receptors of innate
immunity. Circ Res. 108:235–248. 2011.
|
|
33
|
Borén J, Chapman MJ, Krauss RM, Packard
CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls
SJ, et al: Low-density lipoproteins cause atherosclerotic
cardiovascular disease: Pathophysiological, genetic, and
therapeutic insights: A consensus statement from the European
atherosclerosis society consensus panel. Eur Heart J. 41:2313–2330.
2020.
|
|
34
|
Huang C, Hu YW, Zhao JJ, Ma X, Zhang Y,
Guo FX, Kang CM, Lu JB, Xiu JC, Sha YH, et al: Long noncoding RNA
HOXC-AS1 suppresses Ox-LDL-induced cholesterol accumulation through
promoting HOXC6 expression in THP-1 macrophages. DNA Cell Biol.
35:722–729. 2016.
|
|
35
|
Libby P and Hansson GK: From focal lipid
storage to systemic inflammation: JACC review topic of the week. J
Am Coll Cardiol. 74:1594–1607. 2019.
|
|
36
|
Lee JY, Park KS, Cho EJ, Joo HK, Lee SK,
Lee SD, Park JB, Chang SJ and Jeon BH: Human HOXA5 homeodomain
enhances protein transduction and its application to vascular
inflammation. Biochem Biophys Res Commun. 410:312–316. 2011.
|
|
37
|
Chen Y and Gorski DH: Regulation of
angiogenesis through a microRNA (miR-130a) that down-regulates
antiangiogenic homeobox genes GAX and HOXA5. Blood. 111:1217–1226.
2008.
|
|
38
|
Dunn J, Qiu H, Kim S, Jjingo D, Hoffman R,
Kim CW, Jang I, Son DJ, Kim D, Pan C, et al: Flow-dependent
epigenetic DNA methylation regulates endothelial gene expression
and atherosclerosis. J Clin Invest. 124:3187–3199. 2014.
|
|
39
|
Trigueros-Motos L, González-Granado JM,
Cheung C, Fernández P, Sánchez-Cabo F, Dopazo A, Sinha S and Andrés
V: Embryological-origin-dependent differences in homeobox
expression in adult aorta: Role in regional phenotypic variability
and regulation of NF-κB activity. Arterioscler Thromb Vasc Biol.
33:1248–1256. 2013.
|
|
40
|
Liu S, Gao J and Wang S: HOXA9 inhibitors
promote microcirculation of coronary arteries in rats via
downregulating E-selectin/VCAM-1. Exp Ther Med. 22:8712021.
|
|
41
|
Bandyopadhyay S, Ashraf MZ, Daher P, Howe
PH and DiCorleto PE: HOXA9 participates in the transcriptional
activation of E-selectin in endothelial cells. Mol Cell Biol.
27:4207–4216. 2007.
|
|
42
|
Trivedi CM, Patel RC and Patel CV:
Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent
activation of endothelium. Atherosclerosis. 195:e50–e60. 2007.
|
|
43
|
Patel CV, Sharangpani R, Bandyopadhyay S
and DiCorleto PE: Endothelial cells express a novel, tumor necrosis
factor-alpha-regulated variant of HOXA9. J Biol Chem.
274:1415–1422. 1999.
|
|
44
|
Souilhol C, Gauci I, Feng S, Tardajos
Ayllon B, Mahmoud M, Canham L, Fragiadaki M, Serbanovic-Canic J,
Ridger V and Evans PC: Homeobox B9 integrates bone morphogenic
protein 4 with inflammation at atheroprone sites. Cardiovasc Res.
116:1300–1310. 2020.
|
|
45
|
Fessner A, Esser JS, Bluhm F, Grundmann S,
Zhou Q, Patterson C, Bode C and Moser M: The transcription factor
HoxB5 stimulates vascular remodelling in a cytokine-dependent
manner. Cardiovasc Res. 101:247–255. 2014.
|
|
46
|
Mace KA, Hansen SL, Myers C, Young DM and
Boudreau N: HOXA3 induces cell migration in endothelial and
epithelial cells promoting angiogenesis and wound repair. J Cell
Sci. 118:2567–2577. 2005.
|
|
47
|
Boudreau NJ and Varner JA: The homeobox
transcription factor Hox D3 promotes integrin alpha5beta1
expression and function during angiogenesis. J Biol Chem.
279:4862–4868. 2004.
|
|
48
|
Myers C, Charboneau A, Cheung I, Hanks D
and Boudreau N: Sustained expression of homeobox D10 inhibits
angiogenesis. Am J Pathol. 161:2099–2109. 2002.
|
|
49
|
Rhoads K, Arderiu G, Charboneau A, Hansen
SL, Hoffman W and Boudreau N: A role for Hox A5 in regulating
angiogenesis and vascular patterning. Lymphat Res Biol. 3:240–252.
2005.
|
|
50
|
Arderiu G, Cuevas I, Chen A, Carrio M,
East L and Boudreau NJ: HoxA5 stabilizes adherens junctions via
increased Akt1. Cell Adh Migr. 1:185–195. 2007.
|
|
51
|
Winnik S, Klinkert M, Kurz H, Zoeller C,
Heinke J, Wu Y, Bode C, Patterson C and Moser M: HoxB5 induces
endothelial sprouting in vitro and modifies intussusceptive
angiogenesis in vivo involving angiopoietin-2. Cardiovasc Res.
83:558–565. 2009.
|
|
52
|
Park H, Choi HJ, Kim J, Kim M, Rho SS,
Hwang D, Kim YM and Kwon YG: Homeobox D1 regulates angiogenic
functions of endothelial cells via integrin β1 expression. Biochem
Biophys Res Commun. 408:186–192. 2011.
|
|
53
|
Bruhl T, Urbich C, Aicher D, Acker-Palmer
A, Zeiher AM and Dimmeler S: Homeobox A9 transcriptionally
regulates the EphB4 receptor to modulate endothelial cell migration
and tube formation. Circ Res. 94:743–751. 2004.
|
|
54
|
Stoll SJ and Kroll J: HOXC9: A key
regulator of endothelial cell quiescence and vascular
morphogenesis. Trends Cardiovasc Med. 22:7–11. 2012.
|
|
55
|
Stoll SJ, Bartsch S, Augustin HG and Kroll
J: The transcription factor HOXC9 regulates endothelial cell
quiescence and vascular morphogenesis in zebrafish via inhibition
of interleukin 8. Circ Res. 108:1367–1377. 2011.
|
|
56
|
Chung N, Jee BK, Chae SW, Jeon YW, Lee KH
and Rha HK: HOX gene analysis of endothelial cell differentiation
in human bone marrow-derived mesenchymal stem cells. Mol Biol Rep.
36:227–235. 2009.
|
|
57
|
Zhang X, Sessa WC and Fernández-Hernando
C: Endothelial transcytosis of lipoproteins in atherosclerosis.
Front Cardiovasc Med. 5:1302018.
|
|
58
|
Gimbrone MA Jr and García-Cardeña G:
Endothelial cell dysfunction and the pathobiology of
atherosclerosis. Circ Res. 118:620–636. 2016.
|
|
59
|
Long X, You G, Wu Q, Zhou Y, Xiao Y, Yu F,
Deng S, Mo R, Song F, Huang J and Tian M: HomeoboxC6 affects the
apoptosis of human vascular endothelial cells and is involved in
atherosclerosis. J Cell Physiol. 236:1913–1925. 2021.
|
|
60
|
Zhang X, Liu X and Liu L: The influence of
HOXB2 anti-sense oligodeoxynucleotides on the proliferation and
expression of human umbilical vein endothelial cells. Zhonghua Shao
Shang Za Zhi. 17:348–350. 2001.In Chinese.
|
|
61
|
Campbell JH and Campbell GR: Smooth muscle
phenotypic modulation-a pesonal experience. Arterioscler Thromb
Vasc Biol. 32:1784–1789. 2012.
|
|
62
|
Basatemur GL, Jørgensen HF, Clarke MCH,
Bennett MR and Mallat Z: Vascular smooth muscle cells in
atherosclerosis. Nat Rev Cardiol. 16:727–744. 2019.
|
|
63
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016.
|
|
64
|
Long X, You G, Wu Q, Zhou Y, Yu F, Xiao Y,
Deng S, Song F, Huang J and Tian M: Abnormal expression of homeobox
c6 in the atherosclerotic aorta and its effect on proliferation and
migration of rat vascular smooth muscle cells. Acta Biochim Biophys
Sin (Shanghai). 52:935–943. 2020.
|
|
65
|
Gibbons GH and Dzau VJ: The emerging
concept of vascular remodeling. N Engl J Med. 330:1431–1438.
1994.
|
|
66
|
Kimura M, Horie T, Baba O, Ide Y, Tsuji S,
Ruiz Rodriguez R, Watanabe T, Yamasaki T, Otani C, Xu S, et al:
Homeobox A4 suppresses vascular remodeling by repressing YAP/TEAD
transcriptional activity. EMBO Rep. 21:e483892020.
|
|
67
|
Yu T, Wang T, Kuang S, Zhao G, Zhou K and
Zhang H: A microRNA-17-5p/homeobox B13 axis participates in the
phenotypic modulation of vascular smooth muscle cells. Mol Med Rep.
24:7312021.
|
|
68
|
Koelwyn GJ, Corr EM, Erbay E and Moore KJ:
Regulation of macrophage immunometabolism in atherosclerosis. Nat
Immune. 19:526–537. 2018.
|
|
69
|
Chinetti-Gbaguidi G, Colin S and Staels B:
Macrophage subsets in atherosclerosis. Nat Rev Cardiol. 12:10–17.
2015.
|
|
70
|
Xu R, Li C, Wu Y, Shen L, Ma J, Qian J and
Ge J: Role of KCa3.1 channels in macrophage polarization and its
relevance in atherosclerotic plaque instability. Arterioscler
Thromb Vasc Biol. 37:226–236. 2017.
|
|
71
|
Shapouri-Moghaddam A, Mohammadian S,
Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi
A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization,
and function in health and disease. J Cell Physiol. 233:6425–6440.
2018.
|
|
72
|
Tabas I and Bornfeldt KE: Macrophage
phenotype and function in different stages of atherosclerosis. Circ
Res. 118:653–667. 2016.
|
|
73
|
Hyam SR, Lee IA, Gu W, Kim KA, Jeong JJ,
Jang SE, Han MJ and Kim DH: Arctigenin ameliorates inflammation in
vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing
M1 macrophages to M2-like macrophages. Eur J Pharmacol. 708:21–29.
2013.
|
|
74
|
Devaraj S and Jialal I: C-reactive protein
polarizes human macrophages to an M1 phenotype and inhibits
transformation to the M2 phenotype. Arterioscler Thromb Vasc Biol.
31:1397–1402. 2011.
|
|
75
|
Cao W, Zhang T, Feng R, Xia T, Huang H,
Liu C and Sun C: Hoxa5 alleviates obesity-induced chronic
inflammation by reducing ER stress and promoting M2 macrophage
polarization in mouse adipose tissue. J Cell Mol Med. 23:7029–7042.
2019.
|
|
76
|
Jing Y, Gao B, Han Z and Xin S: HOXA5
induces M2 macrophage polarization to attenuate carotid
atherosclerosis by activating MED1. IUBMB Life. 73:1142–1152.
2021.
|
|
77
|
Roux M and Zaffran S: Hox genes in
cardiovascular development and diseases. J Dev Biol. 4:142016.
|
|
78
|
Nguyen NUN, Canseco DC, Xiao F, Nakada Y,
Li S, Lam NT, Muralidhar SA, Savla JJ, Hill JA, Le V, et al: A
calcineurin-Hoxb13 axis regulates growth mode of mammalian
cardiomyocytes. Nature. 582:271–276. 2020.
|
|
79
|
Miano JM, Firulli AB, Olson EN, Hara P,
Giachelli CM and Schwartz SM: Restricted expression of homeobox
genes distinguishes fetal from adult human smooth muscle cells.
Proc Natl Acad Sci USA. 93:900–905. 1996.
|
|
80
|
Gorski DH and Walsh K: The role of
homeobox genes in vascular remodeling and angiogenesis. Circ Res.
87:865–872. 2000.
|
|
81
|
Klein D, Benchellal M, Kleff V, Jakob HG
and Ergün S: Hox genes are involved in vascular wall-resident
multipotent stem cell differentiation into smooth muscle cells. Sci
Rep. 3:21782013.
|
|
82
|
Wu Y, Moser M, Bautch VL and Patterson C:
HoxB5 is an upstream transcriptional switch for differentiation of
the vascular endothelium from precursor cells. Mol Cell Biol.
23:5680–5691. 2003.
|
|
83
|
Mace KA, Restivo TE, Rinn JL, Paquet AC,
Chang HY, Young DM and Boudreau NJ: HOXA3 modulates injury-induced
mobilization and recruitment of bone marrow-derived cells. Stem
Cells. 27:1654–1665. 2009.
|
|
84
|
Chojnowski JL, Trau HA, Masuda K and
Manley NR: Temporal and spatial requirements for Hoxa3 in mouse
embryonic development. Dev Biol. 415:33–45. 2016.
|
|
85
|
Zhang X, Liu G, Ding L, Jiang T, Shao S,
Gao Y and Lu Y: HOXA3 promotes tumor growth of human colon cancer
through activating EGFR/Ras/Raf/MEK/ERK signaling pathway. J Cell
Biochem. 119:2864–2874. 2018.
|
|
86
|
Li Z, Xu H, Liu X, Hong Y, Lou H, Liu H,
Bai X, Wang L, Li X, Monayo SM, et al: GDF11 inhibits cardiomyocyte
pyroptosis and exerts cardioprotection in acute myocardial
infarction mice by upregulation of transcription factor HOXA3. Cell
Death Dis. 11:9172020.
|
|
87
|
Li T, Qian D, Guoyan J and Lei Z:
Downregulated long noncoding RNA LUCAT1 inhibited proliferation and
promoted apoptosis of cardiomyocyte via miR-612/HOXA13 pathway in
chronic heart failure. Eur Rev Med Pharmacol Sci. 24:385–395.
2020.
|
|
88
|
Aonuma T, Moukette B, Kawaguchi S,
Barupala NP, Sepúlveda MN, Frick K, Tang Y, Guglin M, Raman SV, Cai
C, et al: MiR-150 attenuates maladaptive cardiac remodeling
mediated by long noncoding RNA MIAT and directly represses
profibrotic Hoxa4. Circ Heart Fail. 15:e0086862022.
|
|
89
|
Zhou G, Li C, Feng J, Zhang J and Fang Y:
lncRNA UCA1 Is a novel regulator in cardiomyocyte hypertrophy
through targeting the miR-184/HOXA9 axis. Cardiorenal Med.
8:130–139. 2018.
|
|
90
|
Wen ZQ, Li SH, Shui X, Tang LL, Zheng JR
and Chen L: LncRNA PEG10 aggravates cardiac hypertrophy through
regulating HOXA9. Eur Rev Med Pharmacol Sci. 23(3 Suppl):
S281–S286. 2019.
|
|
91
|
Cao X, Zhang Z, Wang Y, Shan W, Wang R,
Mao S, Ding S, Pang C, Li B, Zhou J, et al: MiR-27a-3p/Hoxa10 axis
regulates angiotensin II-induced cardiomyocyte hypertrophy by
targeting Kv4.3 expression. Front Pharmacol. 12:6803492021.
|
|
92
|
Zhang Y, Da Q, Cao S, Yan K, Shi Z, Miao
Q, Li C, Hu L, Sun S, Wu W, et al: HINT1 (histidine triad
nucleotide-binding protein 1) attenuates cardiac hypertrophy via
suppressing HOXA5 (homeobox A5) expression. Circulation.
144:638–654. 2021.
|
|
93
|
Fantini S, Salsi V and Zappavigna V: HOX
cluster-embedded micro-RNAs and cancer. Biochim Biophys Acta Rev
Cancer. 1869:230–247. 2018.
|
|
94
|
Botti G, De Chiara A, Di Bonito M, Cerrone
M, Malzone MG, Collina F and Cantile M: Noncoding RNAs within the
HOX gene network in tumor pathogenesis and progression. J Cell
Physiol. 234:395–413. 2018.
|
|
95
|
Wang Y, Dang Y, Liu J and Ouyang X: The
function of homeobox genes and lncRNAs in cancer. Oncol Lett.
12:1635–1641. 2016.
|
|
96
|
De Kumar B and Krumlauf R: HOXs and
lincRNAs: Two sides of the same coin. Sci Adv. 2:e15014022016.
|
|
97
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007.
|
|
98
|
Sessa L, Breiling A, Lavorgna G, Silvestri
L, Casari G and Orlando V: Noncoding RNA synthesis and loss of
polycomb group repression accompanies the colinear activation of
the human HOXA cluster. RNA. 13:223–239. 2007.
|
|
99
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16:1362017.
|
|
100
|
Pang JL, Wang JW, Hu PY, Jiang JS and Yu
C: HOTAIR alleviates ox-LDL-induced inflammatory response in
Raw264.7 cells via inhibiting NF-κB pathway. Eur Rev Med Pharmacol
Sci. 22:6991–6998. 2018.
|
|
101
|
Liu J, Huang GQ and Ke ZP: Silence of long
intergenic noncoding RNA HOTAIR ameliorates oxidative stress and
inflammation response in ox-LDL-treated human macrophages by
upregulating miR-330-5p. J Cell Physiol. 234:5134–5142. 2019.
|
|
102
|
Wu K, Liu F, Wu W, Chen Y, Wu H and Zhang
W: Long non-coding RNA HOX transcript antisense RNA (HOTAIR)
suppresses the angiogenesis of human placentation by inhibiting
vascular endothelial growth factor A expression. Reprod Fertil Dev.
31:377–385. 2019.
|
|
103
|
Peng Y, Meng K, Jiang L, Zhong Y, Yang Y,
Lan Y, Zeng Q and Cheng L: Thymic stromal lymphopoietin-induced
HOTAIR activation promotes endothelial cell proliferation and
migration in atherosclerosis. Biosci Rep. 37:BSR201703512017.
|
|
104
|
Xue H, Wang B and Xue YS: LncRNA HOTAIR
regulates the proliferation and apoptosis of vascular smooth muscle
cells through targeting miRNA-130b-3p/PPARα axis. Eur Rev Med
Pharmacol Sci. 23:10989–10995. 2019.
|
|
105
|
Tan L, Xu Q, Wang Q, Shi R and Zhang G:
Identification of key genes and pathways affected in epicardial
adipose tissue from patients with coronary artery disease by
integrated bioinformatics analysis. PeerJ. 8:e87632020.
|
|
106
|
Liang J, Cao Y, He M, Li W, Huang G, Ma T,
Li M, Huang Y, Huang X and Hu Y: AKR1C3 and its transcription
factor HOXB4 are promising diagnostic biomarkers for acute
myocardial infarction. Front Cardiovasc Med. 8:6942382021.
|
|
107
|
Qiu X, Lin J, Chen Y, Liang B and Li L:
Identification of Hub genes associated with abnormal endothelial
function in early coronary atherosclerosis. Biochem Genet.
60:1189–1204. 2022.
|
|
108
|
Golpon HA, Geraci MW, Moore MD, Miller HL,
Miller GJ, Tuder RM and Voelkel NF: HOX genes in human lung:
Altered expression in primary pulmonary hypertension and emphysema.
Am J Pathol. 158:955–966. 2001.
|
|
109
|
Tehrani Z and Lin S: Antagonistic
interactions of hedgehog, Bmp and retinoic acid signals control
zebrafish endocrine pancreas development. Development. 138:631–640.
2011.
|
|
110
|
Shi Y: Generation of functional
insulin-producing cells from human embryonic stem cells in vitro.
Methods Mol Biol. 636:79–85. 2010.
|
